Your browser doesn't support javascript.
loading
Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted Therapies.
Pflug, Natali; Chakupurakal, Geothy; Fink, Anna-Maria; Robrecht, Sandra; Herling, Marco; Cramer, Paula; Holtick, Udo; Theurich, Sebastian; Schetelig, Johannes; Fischer, Kirsten; Ritgen, Matthias; Scheid, Christof; Eichhorst, Barbara; Dreger, Peter; Hallek, Michael; von Bergwelt-Baildon, Michael.
Afiliação
  • Pflug N; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany.
  • Chakupurakal G; Praxis für Hämatologie und Onkologie, Koblenz, Germany.
  • Fink AM; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany.
  • Robrecht S; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany.
  • Herling M; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany.
  • Cramer P; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany.
  • Holtick U; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany.
  • Theurich S; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany.
  • Schetelig J; Department of Medicine III, LMU University Hospital, Munich, Germany.
  • Fischer K; German Cancer Consortium (DKTK), partner site Munich, Germany.
  • Ritgen M; Medizinische Klinik und Poliklinik I, University Hospital Dresden, Germany.
  • Scheid C; DKMS Clinical Trials Unit, Dresden, Germany.
  • Eichhorst B; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany.
  • Dreger P; University Clinic of Schleswig-Holstein, Kiel, Germany.
  • Hallek M; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany.
  • von Bergwelt-Baildon M; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany.
Hemasphere ; 5(12): e664, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34881358
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hemasphere Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hemasphere Ano de publicação: 2021 Tipo de documento: Article